This controversy has put a spotlight on the governance of medical education in India. It is a reminder that while political decisions shape institutions, they must be made with careful consideration of expertise, credibility, and the future of healthcare.
The vision of a ₹10 lakh crore pharma industry and a healthcare system that Is both accessible and affordable is ambitious, but with the right strategies, India is well on its way to making this vision a reality.